Industry Insights: Early Safety and Human-Relevant Models Gain Strategic Weight
Published on February 18, 2026
How early is early enough for safety? And how closely should preclinical models reflect human biology before major investment decisions are made? Recent industry updates suggest that these questions are moving to the center of strategic planning, with implications for how discovery and development programs are structured.
